Fasenra pen 30 MG/mlml
Ended Awarded
- Contract number
- SPE2DB25FBJF3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,650
Award facts
- Contract value 100% obligated
- $13,650.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,650 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FASENRA Pen 30 mg/mL, a pharmaceutical product for respiratory treatment. This non-competitive delivery order, issued on September 14, 2025, with completion targeted for October 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts covering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
This delivery order falls within AmerisourceBergen's $999,999,999 prime IDC with DLA Troop Support Medical, which extends through December 2026 and enables the company to supply pharmaceutical products globally to support military healthcare programs. The contract demonstrates AmerisourceBergen's capability to fulfill federal medical supply requirements through its established relationship with the Defense Logistics Agency, which is positioning the company for potential participation in the upcoming Pharmaceutical Prime Vendor Global Program Generation V contracts. The firm fixed-price structure and straightforward delivery timeline reflect the streamlined procurement process typical of established indefinite delivery vehicles for routine pharmaceutical replenishment.
Quick answers
Who was awarded contract SPE2DB25FBJF3?
SPE2DB25FBJF3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 14, 2025.
How much is contract SPE2DB25FBJF3 worth?
The government has obligated $13,650 on SPE2DB25FBJF3.
Is contract SPE2DB25FBJF3 an order under another contract?
Yes. SPE2DB25FBJF3 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBJF3 competed?
The extent of competition for SPE2DB25FBJF3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award